Cameron Alan J, Souto Enrico O, Smyrk Thomas C
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Am J Gastroenterol. 2002 Jun;97(6):1375-80. doi: 10.1111/j.1572-0241.2002.05669.x.
Intestinal metaplasia in Barrett's esophagus predisposes to esophageal adenocarcinoma. Intestinal metaplasia of the cardia is a common finding in persons without cancer. Many adenocarcinomas of the esophagogastric junction are large enough to obliterate any underlying intestinal metaplasia. To estimate how often adenocarcinoma of the esophagogastric junction arises in intestinal metaplasia, we studied small adenocarcinomas of the esophagogastric junction.
Resection patients had adenocarcinomas 2 cm or smaller, within 2 cm of the esophagogastric junction. Age- and sex-matched controls had resection for squamous carcinoma. Saved and new histological slides from the esophagogastric junction were examined, with additional stains.
Intestinal metaplasia was found in 86% (19/22) of adenocarcinoma cases, versus 32% (7/22) of controls (p < 0.001). Intestinal metaplasia with high or low grade dysplasia was associated with 64% (14/22) of adenocarcinomas and with 5% (1/22) of controls (p < 0.001). Excluding four cases with long and three with short Barrett's esophagus, 80% (12/15) of adenocarcinomas had associated intestinal metaplasia, 53% (8/15) with dysplasia. Most adenocarcinoma cases had the incomplete type of intestinal metaplasia with a Barrett type cytokeratin 7/20 staining pattern. Helicobacter pylori were seen in one adenocarcinoma and five control cases.
Most adenocarcinomas of the esophagogastic junction arise in the background of intestinal metaplasia, sometimes in an endoscopically visible Barrett's esophagus, more often in small areas of intestinal metaplasia of the cardia. In cases of adenocarcinoma, the intestinal metaplasia resembled that found in Barrett's esophagus, and was not associated with H. pylori.
巴雷特食管中的肠化生易引发食管腺癌。贲门肠化生在无癌症人群中很常见。许多食管胃交界腺癌体积足够大,会掩盖任何潜在的肠化生。为了评估食管胃交界腺癌在肠化生中出现的频率,我们研究了食管胃交界小腺癌。
手术切除患者的腺癌位于食管胃交界2厘米范围内且大小为2厘米或更小。年龄和性别匹配的对照组因鳞状细胞癌接受手术切除。对食管胃交界保存的和新的组织学切片进行检查,并进行额外染色。
腺癌病例中86%(19/22)发现肠化生,而对照组为32%(7/22)(p<0.001)。伴有高级别或低级别异型增生的肠化生与64%(14/22)的腺癌相关,与5%(1/22)的对照组相关(p<0.001)。排除4例长段巴雷特食管和3例短段巴雷特食管病例后,80%(12/15)的腺癌伴有肠化生,53%(8/15)伴有异型增生。大多数腺癌病例为不完全型肠化生,具有巴雷特型细胞角蛋白7/20染色模式。在1例腺癌和5例对照病例中发现幽门螺杆菌。
大多数食管胃交界腺癌发生在肠化生背景下,有时在内镜可见的巴雷特食管中,更多时候在贲门小面积肠化生区域。在腺癌病例中,肠化生类似于巴雷特食管中发现的肠化生,且与幽门螺杆菌无关。